Five AI-enhanced clinical trial start-ups to watch in 2021
We look at some of the most exciting startups harnessing artificial intelligence to improve clinical trials.
ByData
GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on the industry now the regulation…
New Data Suggest HCV Remains a Problem in the US
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in the US
Industry Viewpoints: The Challenges of Clinical Data Management
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising technologies taking over the industry
How Can Blockchain Disrupt the Pharma Industry?
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young biotech punches above its weight
Industry Viewpoints: Leveraging eSource in Data Management
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management trends and challenges
Perfect Communication? That’s an Oxymoron!
Audrey Hill, Senior Director, Data Management, Advaxis, Inc., explains the keys to clear communication in clinical trial processes